MDT240823C78000
- 6.65
- 0.000.00%
Medtronic Newsroom
Insulin Pump Market Research Report 2024-2032 With Competitive Analysis of Medtronic, Insulet, Tandem Diabetes Care, Roche, Insulet, Ypsomed, and Microtech Medical
Should You Buy, Sell or Hold Medtronic (MDT) Before Q1 Earnings?
As Medtronic (NYSE:MDT) Increases 4.2% This Past Week, Investors May Now Be Noticing the Company's Three-year Earnings Growth
Barclays Maintains Medtronic(MDT.US) With Buy Rating, Maintains Target Price $104
Medtronic (MDT) Gets a Buy From Barclays
Medtronic Stock: Here's What to Expect From Q1 Earnings
Tesla, Palo Alto Networks, Estee Lauder, FuboTV, and More Stock Market Movers
The Trader: Medtronic Stock Has Hit Been by Anti-Obesity Concerns. Why It Should Rebound. -- Barron's
Medtronic To Go Ex-Dividend On September 27th, 2024 With 0.7 USD Dividend Per Share
Catalyst Watch: Eyes on Jackson Hole, Target Earnings, and Canadian Rails Disruption
Unusual Options Activity: CRWD, GEV and Others Attract Market Bets, CRWD V/OI Ratio Reaches 70.8
Express News | Medtronic PLC - Approved Company's Cash Dividend for Q2 of Fiscal Year 2025 of $0.70 per Ordinary Share
TD Cowen Maintains Medtronic(MDT.US) With Buy Rating, Maintains Target Price $95
Press Releases
Medtronic Announces Partnership With Abbott to Improve Faltering Diabetes Care Segment
Express News | Medtronic PLC : UBS Raises to Neutral From Sell
Express News | Medtronic PLC : UBS Raises Target Price to $90 From $76
Medtronic Upgraded at UBS on Diabetes Turnaround
Medtronic (MDT) Progresses in CGM With New Approval, Alliance
Seeking Clues to Medtronic (MDT) Q1 Earnings? A Peek Into Wall Street Projections for Key Metrics